Dr Debashis Sarker Academics Senior Lecturer and Consultant in Medical Oncology Contact details debashis.sarker@kcl.ac.uk
Serum Immunoglobulin G Is Associated With Decreased Risk of Pancreatic Cancer in the Swedish AMORIS Study Sollie, S., Santaolalla, A., Michaud, D. S., Sarker, D., Karagiannis, S. N., Josephs, D. H., Hammar, N., Walldius, G., Garmo, H., Holmberg, L., Jungner, I. & Van Hemelrijck, M., 28 Feb 2020, In : Frontiers in oncology. 10, 263. Research output: Contribution to journal - Article. DOIs: https://doi.org/10.3389/fonc.2020.00263 Serum immunoglobulin G is associated with decreased risk of pancreatic cancer in the Swedish AMORIS study Sollie, S., Santaolalla, A., Michaud, D. S., Sarker, D., Karagiannis, S. N., Josephs, D. H., Hammar, N., Walldius, G., Garmo, H., Holmberg, L., Jungner, I. & Van Hemelrijck, M., 14 Feb 2020, (Accepted/In press) In : Frontiers in oncology. Research output: Contribution to journal - Article First-in-human study of the PARP/tankyrase inhibitor E7449 in patients with advanced solid tumours and evaluation of a novel drug-response predictor Sarker, D., 2020, In : British journal of cancer. Research output: Contribution to journal - Article. DOIs: https://doi.org/10.1038/s41416-020-0916-5 MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial Sarker, D., 2020, In : Clinical Cancer Research. Research output: Contribution to journal - Article. DOIs: https://doi.org/10.1158/1078-0432.CCR-20-0414 NET-02 trial protocol: a multicentre, randomised, parallel group, open-label, phase II, single-stage selection trial of liposomal irinotecan (nal-IRI) and 5-fluorouracil (5-FU)/folinic acid or docetaxel as second-line therapy in patients with progressive poorly differentiated extrapulmonary neuroendocrine carcinoma (NEC) Sarker, D., 2020, In : BMJ Open. Research output: Contribution to journal - Article. DOIs: https://doi.org/10.1136/bmjopen-2019-034527 Serum Immunoglobulin G Is Associated With Decreased Risk of Pancreatic Cancer in the Swedish AMORIS Study Sollie, S., Santaolalla, A., Michaud, D. S., Sarker, D., Karagiannis, S. N., Josephs, D. H., Hammar, N., Walldius, G., Garmo, H., Holmberg, L., Jungner, I. & Van Hemelrijck, M., 2020, In : Frontiers in oncology. 10, p. 263 Research output: Contribution to journal - Article. DOIs: https://doi.org/10.3389/fonc.2020.00263 First-in-human phase i study of fisogatinib (BLU-554) validates aberrant FGF19 signaling as a driver event in hepatocellular carcinoma Kim, R. D., Sarker, D., Meyer, T., Yau, T., Macarulla, T., Park, J. W., Choo, S. P., Hollebecque, A., Sung, M. W., Lim, H. Y., Mazzaferro, V., Trojan, J., Zhu, A. X., Yoon, J. H., Sharma, S., Lin, Z. Z., Chan, S. L., Faivre, S., Feun, L. G., Yen, C. J. & 15 others, Dufour, J. F., Palmer, D. H., Llovet, J. M., Manoogian, M., Tugnait, M., Stransky, N., Hagel, M., Kohl, N. E., Lengauer, C., Sherwin, C. A., Schmidt-Kittler, O., Hoeflich, K. P., Shi, H., Wolf, B. B. & Kang, Y. K., 1 Dec 2019, In : Cancer discovery. 9, 12, p. 1696-1707 12 p. Research output: Contribution to journal - Article. DOIs: https://doi.org/10.1158/2159-8290.CD-19-0555 Chronic inflammation markers are associated with risk of pancreatic cancer in the Swedish AMORIS cohort study Sollie, S., Michaud, D. S., Sarker, D., Karagiannis, S. N., Josephs, D. H., Hammar, N., Santaolalla, A., Walldius, G., Garmo, H., Holmberg, L., Jungner, I. & Van Hemelrijck, M., 29 Aug 2019, In : BMC Cancer. 19, 1, 858. Research output: Contribution to journal - Article. DOIs: https://doi.org/10.1186/s12885-019-6082-6 Hepatocellular Carcinoma as a Complication of Vascular Disease of the Liver After Fontan Procedure Mazzarelli, C., Cannon, M. D., Hudson, M., Heaton, N., Sarker, D., Kane, P., Quaglia, A. & Suddle, A., 1 Feb 2019, In : Hepatology. 69, 2, p. 911-913 3 p. Research output: Contribution to journal - Article. DOIs: https://doi.org/10.1002/hep.30194 Delayed adverse events in phase I trials of molecularly targeted and cytotoxic agents Jordan, E. J., Spicer, J. & Sarker, D., 21 Sep 2018, In : Oncotarget. 9, 74, p. 33961-33971 11 p. Research output: Contribution to journal - Article. DOIs: https://doi.org/10.18632%2Foncotarget.26104 View all publications